Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York, USA.
Cardiac Surgery Center, Cardiologique du Nord de Saint-Denis, Paris, France.
Eur J Neurol. 2024 May;31(5):e16243. doi: 10.1111/ene.16243. Epub 2024 Feb 20.
The conceptualization of brain death (BD) was pivotal in the shaping of judicial and medical practices. Nonetheless, media reports of alleged recovery from BD reinforced the criticism that this construct is a self-fulfilling prophecy (by treatment withdrawal or organ donation). We meta-analyzed the natural history of BD when somatic support (SS) is maintained.
Publications on BD were eligible if the following were reported: aggregated data on its natural history with SS; and patient-level data that allowed censoring at the time of treatment withdrawal or organ donation. Endpoints were as follows: rate of somatic expiration after BD with SS; BD misdiagnosis, including "functionally brain-dead" patients (FBD; i.e. after the pronouncement of brain-death, ≥1 findings were incongruent with guidelines for its diagnosis, albeit the lethal prognosis was not altered); and length and predictors of somatic survival.
Forty-seven articles were selected (1610 patients, years: 1969-2021). In BD patients with SS, median age was 32.9 years (range = newborn-85 years). Somatic expiration followed BD in 99.9% (95% confidence interval = 89.8-100). Mean somatic survival was 8.0 days (range = 1.6 h-19.5 years). Only age at BD diagnosis was an independent predictor of somatic survival length (coefficient = -11.8, SE = 4, p < 0.01). Nine BD misdiagnoses were detected; eight were FBD, and one newborn fully recovered. No patient ever recovered from chronic BD (≥1 week somatic survival).
BD diagnosis is reliable. Diagnostic criteria should be fine-tuned to avoid the small incidence of misdiagnosis, which nonetheless does not alter the prognosis of FBD patients. Age at BD diagnosis is inversely proportional to somatic survival.
脑死亡(BD)概念的提出对司法和医疗实践产生了重要影响。然而,媒体报道的所谓 BD 患者康复案例,强化了人们对这一概念是自我实现预言的批评(因停止治疗或器官捐献而导致)。本研究通过对维持躯体支持(SS)时 BD 的自然史进行荟萃分析,旨在对此进行验证。
如果满足以下条件,即可纳入关于 BD 的研究:报告了 SS 情况下 BD 自然史的汇总数据;且患者水平数据允许在停止治疗或器官捐献时进行删失。研究终点如下:BD 后在维持 SS 情况下躯体衰竭的发生率;BD 误诊,包括“功能脑死亡”患者(FBD;即脑死亡宣告后,尽管致命预后未改变,但≥1项发现与诊断指南不一致);以及躯体存活时间及预测因素。
共选择了 47 篇文章(1610 例患者,年份:1969-2021 年)。在接受 SS 的 BD 患者中,中位年龄为 32.9 岁(范围=新生儿-85 岁)。BD 后 99.9%(95%置信区间=89.8-100)的患者出现躯体衰竭。平均躯体存活时间为 8.0 天(范围=1.6 小时-19.5 年)。只有 BD 诊断时的年龄是躯体存活时间的独立预测因素(系数=-11.8,SE=4,p<0.01)。共检测到 9 例 BD 误诊,其中 8 例为 FBD,1 例新生儿完全康复。从未有慢性 BD(≥1 周的躯体存活)患者康复。
BD 诊断可靠。诊断标准应进行微调,以避免小概率误诊的发生,不过这不会改变 FBD 患者的预后。BD 诊断时的年龄与躯体存活时间呈反比。